Minimal residual disease predicts superior survival in patients with multiple myeloma: a meta-analysis

IMPORTANCE: Numerous studies have evaluated the prognostic value of minimal residual disease (MRD) in multiple myeloma (MM). Most studies were small and varied in terms of patient population, treatment, and MRD assessment methods. OBJECTIVE: To evaluate the utility of MRD detection in patients with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Munshi, Nikhil C., Avet-Loiseau, Herve, Rawstron, Andy C., Owen, Roger G., Child, J. Anthony, Thakurta, Anjan, Sherrington, Paul, Samur, Mehmet Kemal, Georgieva, Anna, Anderson, Kenneth C., Gregory, Walter M.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5943640/
https://ncbi.nlm.nih.gov/pubmed/27632282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.3160
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars